510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K901972Substantially Equivalent

Add'l Claimed Intended Use for Ideia(tm) Chlamydia

Novo Nordisk Diagnostics, Ltd., Cambridge Cb4 4ws England, GB / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K901972 is the FDA 510(k) clearance record for ADD'L CLAIMED INTENDED USE FOR IDEIA(TM) CHLAMYDIA, a class I device, cleared for Novo Nordisk Diagnostics, Ltd. on under FDA product code LJC (Enzyme Linked Immunoabsorbent Assay, (Chlamydiae Group)). FDA records list 2 510(k) clearances for Novo Nordisk Diagnostics, Ltd., from to . As of , FDA records show no recalls naming K901972.

Clearance record

Decision date
Received
(127 days to decision)
Product code
LJC Enzyme Linked Immunoabsorbent Assay, (Chlamydiae Group)
Regulation
21 CFR 866.3120
Device class
Class I
Review panel
Microbiology
Applicant
Novo Nordisk Diagnostics, Ltd. Dirac House, St. John'S, Cambridge Cb4 4ws England, GB
Third party review
No

Clearances, product code LJC

Trailing 12 months

FDA records hold no clearances under product code LJC in the trailing twelve months.

FDA records show no clearances under product code LJC in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LJC, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260